Unstable angina: the first 48 hours and later in-hospital management

Research output: Contribution to journalArticlepeer-review

Abstract

Unstable angina is a common cardiovascular condition associated with major adverse clinical events. Over the last 15 years, therapeutic advances have dramatically reduced the complication and mortality rates of this serious condition. The standard of therapy in patients with unstable angina now incorporates the combined use of potent antithrombotic (aspirin, clopidogrel, heparin and glycoprotein IIb/IIIa receptor antagonists) and anti-anginal (beta-blockade and intravenous nitrates) regimens complemented by the selective and judicious application of coronary revascularisation strategies. Increasingly, these invasive and non-invasive therapeutic interventions are being guided not only by the clinical risk profile but also by the determination of serum cardiac and inflammatory markers. Moreover, rapid and intensive management of associated risk factors, such as hypercholesterolaemia, would appear to have potentially substantial benefits even within the acute in-hospital phase of unstable angina.

Original languageEnglish
Pages (from-to)69-87
Number of pages19
JournalBritish Medical Bulletin
Volume59
Publication statusPublished - 2001

Keywords

  • Aged
  • Angina, Unstable
  • Angioplasty, Balloon, Coronary
  • C-Reactive Protein
  • Coronary Artery Bypass
  • Coronary Restenosis
  • Electrocardiography
  • Emergency Treatment
  • Hospitalization
  • Humans
  • Middle Aged
  • Myocardial Revascularization
  • Potassium Channels
  • Risk Assessment
  • Time Factors
  • Troponin

Fingerprint

Dive into the research topics of 'Unstable angina: the first 48 hours and later in-hospital management'. Together they form a unique fingerprint.

Cite this